Spruce Biosciences, Inc.
Spruce Biosciences, Inc. scores highest on Earnings (43) and lowest on Nitro (21). Its PosiPenta is 33.89 out of 100, weaker than most similar companies.
On the Penta Grid this week, Spruce Biosciences, Inc. is Grid #697 of 837 in the Healthcare sector in United States, and Grid #3,374 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Spruce Biosciences, Inc. | 33.89 | 35 | 43 | 21 | 40 | 31 |
| Organogenesis Holdings Inc. | 44.19 | 47 | 58 | 10 | 52 | 54 |
| Health Catalyst, Inc. | 39.73 | 36 | 50 | 51 | 18 | 44 |
| Quanterix Corporation | 43.19 | 45 | 41 | 34 | 49 | 48 |
| Retension Pharmaceuticals, Inc. | 52.19 | 0 | 27 | 93 | 88 | 54 |
| Armata Pharmaceuticals, Inc. | 42.59 | 0 | 38 | 24 | 96 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.01 |
| P/B ratio | 1.36 |
EEarnings
| Trailing EPS | ₹-3705.25 |
| Forward EPS | ₹471.21 |
NNitro
| Price | 3755.45 |
| 52-week high | 15098.79 |
| 52-week low | 3604.85 |
| Fall from 52-week high | 75.1% |
TTorque
| Return on equity (ROE) | -105.98% |
| Debt-to-equity | 0.09 |
AAnchor
| Beta (price swings) | 3.30 |
| Market cap | ₹1,079 Cr |
| Insider holding | 3.37% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Spruce Biosciences, Inc.'s PosiPenta score?
Spruce Biosciences, Inc.'s PosiPenta is 33.89 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Spruce Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Spruce Biosciences, Inc. is Grid #697 of 837 in the Healthcare sector in United States, and Grid #3,374 of 4,000 in United States.
Which PosiPenta pillar is strongest for Spruce Biosciences, Inc.?
Earnings (growth), with a score of 43 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Spruce Biosciences, Inc.?
Nitro (momentum), with a score of 21 out of 100: weaker than most similar companies.
Has Spruce Biosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.79 points, from 30.10 to 33.89.
PositoAI is for research and education only and is not investment advice.